Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance
Journal of Medicinal Chemistry · 08.08.2024 · 67 (15) · 12601-12617
DOI: 10.1021/acs.jmedchem.4c00593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 30.07.2024. Verfasst von Zhongzuo Yan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical U…. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Resistance, Fungal, Amides, Microbial Sensitivity Tests. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
In our previous study, coumarin-containing CYP51 inhibitor A32 demonstrated potent antiresistance activity. However, compound A32 demonstrated unsatisfied metabolic stability, necessitating modifications to overcome these limitations. In this study, α,β-unsaturated amides were used to replace the unstable coumarin ring, which increased metabolic stability by four times while maintaining antifungal activity, including activity against resistant strains. Subsequently, the sterol composition analysis and morphological observation experiments indicated that the target of these novel compounds is lanosterol 14α-demethylase (CYP51). Meanwhile, biofilm growth was inhibited and resistance genes (ERG11, CDR1, CDR2, and MDR1) expression was downregulated to find out how the antiresistance works. Importantly, compound C07 demonstrated the capacity to stimulate reactive oxygen species, thus displaying potent fungicidal activity. Moreover, C07 exhibited encouraging effectiveness in vivo following intraperitoneal administration. Additionally, the most potent compound C07 showed satisfactory pharmacokinetic properties and low toxicity. These α,β-unsaturated amide derivatives, particularly C07, are potential candidates for treating azole-resistant candidiasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Structure-Based Drugs Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
- School of Life Sciences and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
ORCID-Profile: Zhuang Hou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yan, Z., Li, Q., Li, X., Wang, H., Zhao, D., Yu, H., Guo, M., Wang, Y., Wang, X., Xu, H., Mou, Y., Hou, Z., & Guo, C. (2024). Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance. Journal of Medicinal Chemistry, 67(15), 12601-12617. https://doi.org/10.1021/acs.jmedchem.4c00593
Vancouver
Yan Z, Li Q, Li X, Wang H, Zhao D, Yu H, et al. Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance. Journal of Medicinal Chemistry. 2024;67(15):12601-12617. doi:10.1021/acs.jmedchem.4c00593
BibTeX
@article{Yan2024,
author = {Yan, Zhongzuo and Li, Qi and Li, Xinyu and Wang, Huanlin and Zhao, Dongze and Yu, Hao and Guo, Mengbi and Wang, Yitong and Wang, Xin and Xu, Hang and Mou, Yanhua and Hou, Zhuang and Guo, Chun},
title = {Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {15},
pages = {12601--12617},
doi = {10.1021/acs.jmedchem.4c00593}
}
EUVIMED